What: Ongoing research is investigating the relationship between different forms of birth control and long-term health outcomes for women.
Key line: “Early data are intriguing but not yet conclusive,” experts caution.
Source: HealthDay.
Young women now outpace young men in binge drinking, a reversal from previous years.
A study from Intermountain Health finds heart outcome disparities between men and women are decreasing — but gaps in care remain.
Massive cuts eliminated federal maternal and child health divisions and forced out a key director.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
Trump promotes IVF access while cutting the team responsible for tracking it.
Interleukin-6 shows early promise in detecting life-threatening sepsis.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
A deep dive on the ethical implications of working with human embryos.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
Tariffs could raise prices and limit access to Korean skincare products loved by U.S. consumers.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
Federal panel reinforces need for breastfeeding help during and after pregnancy.
New Yorker review highlights how fetal rights are becoming the next legal front.
A state judge loosens the law—but only slightly—on when abortions can be provided.
The Trump administration ends the Pregnancy Risk Assessment Monitoring System (PRAMS), a long-standing CDC data tool.
A New York clerk blocked a Texas court filing targeting a doctor who provided abortion pills.
Over a dozen states are considering bills to expand menopause care and insurance coverage.
Cancer incidence among women continues to rise despite overall progress.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.